Reports
Sale
Global JE (Japanese Encephalitis) Vaccine Market Analysis: By Type: Inactivated, Recombinant, Live attenuated; By Distribution Channel: Hospitals, Retail, Online; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; 2024-2032
Leading Companies in Japanese Encephalitis (JE) Vaccine Market
The report presents a detailed analysis of the following key players in the global JE (Japanese encephalitis) vaccine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Valneva SE
- Bharat Biotech International Limited
- Sanofi
- Chengdu Institute of Biological Products Co., Ltd.
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Japanese Encephalitis (JE) Vaccine Market Report Snapshots
Japanese Encephalitis (JE) Vaccine Market Regional Analysis
Japanese Encephalitis (JE) Vaccine Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global JE (Japanese Encephalitis) Vaccine Market Analysis
8.1 Key Industry Highlights
8.2 Global JE (Japanese Encephalitis) Vaccine Historical Market (2018-2023)
8.3 Global JE (Japanese Encephalitis) Vaccine Market Forecast (2024-2032)
8.4 Global JE (Japanese Encephalitis) Vaccine Market by Type
8.4.1 Inactivated
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Recombinant
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Live Attenuated
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.5 Global JE (Japanese Encephalitis) Vaccine Market by Distribution Channel
8.5.1 Hospitals
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Retail
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Online
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.6 Global JE (Japanese Encephalitis) Vaccine Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
9 North America JE (Japanese Encephalitis) Vaccine Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe JE (Japanese Encephalitis) Vaccine Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific JE (Japanese Encephalitis) Vaccine Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America JE (Japanese Encephalitis) Vaccine Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa JE (Japanese Encephalitis) Vaccine Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Valneva SE
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Sanofi
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Bharat Biotech International Limited
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Chengdu Institute of Biological Products Co. Ltd.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global JE (Japanese Encephalitis) Vaccine Market: Key Industry Highlights, 2017 and 2027
2. Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Type (USD Million), 2018-2023
3. Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Type (USD Million), 2024-2032
4. Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
5. Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
6. Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global JE (Japanese Encephalitis) Vaccine Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 5.5% between 2024 and 2032.
The major drivers of the market, such as a rise in incidences of Japanese encephalitis disease, increasing health awareness, rising demand from the developing regions, increased government investments in the medical sector, and the growing technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the market include the growing R&D activities, growing demand for routine immunisation, and initiation of national immunisation programmes by the governments across several nations.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Inactivated, recombinant, and live attenuated vaccines are the major types of the product in the market.
The leading distribution channels in the market include hospitals, retail, and online.
The major players in the market are Valneva SE, Sanofi, Bharat Biotech International Limited, Chengdu Institute of Biological Products Co. Ltd., among others.
Analyst Review
The global JE (Japanese encephalitis) vaccine market was estimated to value at USD 215.15 million in 2023. It is expected to grow at a CAGR of 5.5% during the forecast period of 2024-2032 to reach a value of USD 348.34 million in 2032. The market is being driven by the rising prevalence of Japanese encephalitis due to increasing mosquito nuisance. Aided by the growing knowledge of routine immunisation and favourable government initiatives, the market is expected to witness a growth during the forecast period.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its type, the market can be segmented into inactivated, recombinant, and live attenuated vaccines. On the basis of distribution channel, the market is divided into hospitals, retail, and online. The major regional markets for global JE (Japanese encephalitis) vaccine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Valneva SE, Sanofi, Bharat Biotech International Limited, Chengdu Institute of Biological Products Co. Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER